Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Toward a National Framework for the Secondary Use of Health Data: An American Medical Informatics Association White Paper
718
Zitationen
7
Autoren
2006
Jahr
Abstract
Secondary use of health data applies personal health information (PHI) for uses outside of direct health care delivery. It includes such activities as analysis, research, quality and safety measurement, public health, payment, provider certification or accreditation, marketing, and other business applications, including strictly commercial activities. Secondary use of health data can enhance health care experiences for individuals, expand knowledge about disease and appropriate treatments, strengthen understanding about effectiveness and efficiency of health care systems, support public health and security goals, and aid businesses in meeting customers' needs. Yet, complex ethical, political, technical, and social issues surround the secondary use of health data. While not new, these issues play increasingly critical and complex roles given current public and private sector activities not only expanding health data volume, but also improving access to data. Lack of coherent policies and standard "good practices" for secondary use of health data impedes efforts to strengthen the U.S. health care system. The nation requires a framework for the secondary use of health data with a robust infrastructure of policies, standards, and best practices. Such a framework can guide and facilitate widespread collection, storage, aggregation, linkage, and transmission of health data. The framework will provide appropriate protections for legitimate secondary use.
Ähnliche Arbeiten
World Medical Association Declaration of Helsinki: Ethical Principles for Medical Research Involving Human Subjects
2003 · 10.818 Zit.
Estimating the mean and variance from the median, range, and the size of a sample
2005 · 8.920 Zit.
SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials
2013 · 6.919 Zit.
The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research
2020 · 5.199 Zit.
The global landscape of AI ethics guidelines
2019 · 4.480 Zit.